2. Academic Validation
  3. Non-canonical inflammasome activation mediates the adjuvanticity of nanoparticles

Non-canonical inflammasome activation mediates the adjuvanticity of nanoparticles

  • Cell Rep Med. 2023 Jan 17;4(1):100899. doi: 10.1016/j.xcrm.2022.100899.
Natalia Muñoz-Wolf 1,  Ross W Ward 2,  Claire H Hearnden 2,  Fiona A Sharp 2,  Joan Geoghegan 3,  Katie O'Grady 2,  Craig P McEntee 2,  Katharine A Shanahan 4,  Coralie Guy 4,  Andrew G Bowie 4,  Matthew Campbell 5,  Carla B Roces 6,  Giulia Anderluzzi 6,  Cameron Webb 6,  Yvonne Perrie 6,  Emma Creagh 4,  Ed C Lavelle 7
Affiliations

Affiliations

  • 1 Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02 R590, Ireland; Translational & Respiratory Immunology Lab, Department of Clinical Medicine, School of Medicine, Trinity Biomedical Sciences Institute, Dublin D02 R590, Ireland; Clinical Medicine Tallaght University Hospital, Dublin D24 NR04, Ireland.
  • 2 Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02 R590, Ireland.
  • 3 Department of Microbiology, Moyne Institute of Preventive Medicine, School of Genetics and Microbiology, Trinity College Dublin, Dublin, Ireland; Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK.
  • 4 School of Biochemistry and Immunology, Trinity Biomedical Science Institute (TBSI), Trinity College Dublin, Dublin D02 R590, Ireland.
  • 5 Smurfit Institute of Genetics, School of Genetics and Microbiology, Trinity College Dublin, Dublin, Ireland.
  • 6 Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
  • 7 Adjuvant Research Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02 R590, Ireland; Centre for Research on Adaptive Nanostructures and Nanodevices (CRANN) & Advanced Materials Bio-Engineering Research Centre (AMBER), Trinity College Dublin, Dublin D02 PN40, Ireland. Electronic address: lavellee@tcd.ie.
PMID: 36652908 DOI: 10.1016/j.xcrm.2022.100899
Abstract

The non-canonical inflammasome sensor caspase-11 and gasdermin D (GSDMD) drive inflammation and Pyroptosis, a type of immunogenic cell death that favors cell-mediated immunity (CMI) in Cancer, Infection, and autoimmunity. Here we show that caspase-11 and GSDMD are required for CD8+ and Th1 responses induced by nanoparticulate vaccine adjuvants. We demonstrate that nanoparticle-induced Reactive Oxygen Species (ROS) are size dependent and essential for CMI, and we identify 50- to 60-nm nanoparticles as optimal inducers of ROS, GSDMD activation, and Th1 and CD8+ responses. We reveal a division of labor for IL-1 and IL-18, where IL-1 supports Th1 and IL-18 promotes CD8+ responses. Exploiting size as a key attribute, we demonstrate that biodegradable poly-lactic co-glycolic acid nanoparticles are potent CMI-inducing adjuvants. Our work implicates ROS and the non-canonical inflammasome in the mode of action of polymeric nanoparticulate adjuvants and establishes Adjuvant size as a key design principle for vaccines against Cancer and intracellular pathogens.

Keywords

CD4; CD8+; CTL; Caspase-1; Caspase-11; GSDMD; IL-1; PLGA; T cells; Th1; adjuvant; cell-mediated immunity; non-canonical inflammasome; polymeric nanoparticles; vaccine.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z